Intelligence · Clinical Pipeline
Infectious disease · Approved programs
Infectious disease programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
- Programs
- 151
Quick answer
Infectious disease Approved programs programs: NovaPharmaNews indexes 151 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Chinese Academy of 28 programs
- Sinovac Research and 20 programs
- United Therapeutics Europe 15 programs
- BRIGHT MINDS BIOSCIENCES 14 programs
- George Institute for 13 programs
- First People's Hospital 11 programs
- Hospital Authority 7 programs
- Disc Medicine 4 programs
- GSK Glaxo Smith 4 programs
- Anaxis Pharma 2 programs
- HOFFMANN-LA ROCHE 2 programs
- Phathom Pharmaceuticals 2 programs
-
lamivudine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Compensated Chronic Hepatitis B
1 trial -
moxifloxacin
Hospital Authority, Hong Kong
Intra-abdominal Infection
1 trial -
oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Hepatitis B
1 trial -
pegylated interferon alpha and plus ribavirin
Hospital Authority, Hong Kong
Chronic Hepatitis C
1 trial -
primaquine
Repatha
Malaria, Vivax
1 trial -
telbivudine (ROADMAP)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatitis B, Chronic
1 trial -
treatment with CAZ-AVI
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Patients With Critically Ill Infections
1 trial
Frequently asked questions
How many infectious disease Approved programs programs exist?
151 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs